Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,810 | 214,317 | 161,953 | 141,141 | 141,823 |
| Marketable Securities | 192,231 | 115,082 | 59,566 | 119,390 | 148,526 |
| TOTAL | $285,953 | $334,519 | $226,270 | $264,966 | $296,417 |
| Non-Current Assets | |||||
| PPE Net | 8,643 | 9,095 | 9,031 | 7,783 | 6,543 |
| Investments And Advances | 33,794 | 21,512 | 0 | 0 | 0 |
| Other Non-Current Assets | 27,056 | 27,243 | 27,897 | 28,061 | 28,600 |
| TOTAL | $69,493 | $57,850 | $36,928 | $35,844 | $35,143 |
| Total Assets | $355,446 | $392,369 | $263,198 | $300,810 | $331,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,868 | 7,161 | 4,172 | 5,842 | 4,093 |
| Accrued Expenses | 23,507 | 17,419 | 16,001 | 17,884 | 14,384 |
| Other current liabilities | N/A | N/A | N/A | 1,700 | 3,060 |
| TOTAL | $34,719 | $25,757 | $21,120 | $26,849 | $23,551 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,829 | 18,184 | 18,515 | 18,226 | 18,067 |
| TOTAL | $17,829 | $18,184 | $18,515 | $18,226 | $18,067 |
| Total Liabilities | $52,548 | $43,941 | $39,635 | $45,075 | $41,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,124 | 85,465 | 70,947 | 69,947 | 69,893 |
| Common Shares | 86 | 85 | 71 | 70 | 70 |
| Retained earnings | -549,259 | -493,877 | -449,801 | -411,214 | -371,596 |
| Other shareholders' equity | 59,863 | 62,213 | 62,326 | 65,726 | 65,667 |
| TOTAL | $302,898 | $348,428 | $223,563 | $255,735 | $289,942 |
| Total Liabilities And Equity | $355,446 | $392,369 | $263,198 | $300,810 | $331,560 |